In the face of the changing dynamics of the PET/CT market, Hitachi Medical Systems America has decided to stop promoting its SceptreP3 product line.
In the face of the changing dynamics of the PET/CT market, Hitachi Medical Systems America has decided to stop promoting its SceptreP3 product line.
The PET/CT market nosedived in the U.S. after the Deficit Reduction Act took effect this year. The DRA took its toll on outpatient clinics, which had accounted for about 70% of past sales. Recent rulings by the Centers for Medicare and Medicaid Services have made the situation worse for these centers by reducing reimbursement for PET scans.
These reimbursement forces created the perfect storm for Hitachi. Despite the value-oriented niche of the SceptreP3 line, its technology was losing ground.
"The SceptreP3 product line is a four-slice PET/CT in a market that has moved to 16-slice PET/CTs," said Sheldon Schaffer, Hitachi Medical Systems America vice president. "Therefore, at this time, we decided not to actively market the system. We will be re-evaluating the PET/CT market and business opportunities later this year."
The company has not set a time line for deciding how - or whether - it will proceed.
"We want to watch the market and, based on its dynamics, will determine the appropriateness of participating in that marketplace," Schaffer said.
The SceptreP3 has not been around that long. The system was cleared by the FDA less than three years ago, in November 2004.
Hitachi Medical Systems America marketed the product as a hybrid PET/CT that was distinct from competitors because of its dual-attenuation correction, which combines both CT and cesium-source attenuation correction to image patients with metal implants and prosthetics. A nonrigid Fusion 7D algorithm provided registration of the PET and CT images, correcting patient motion due to respiration. The AVIA-PACS architecture offered connectivity and workflow solutions, according to the company.
As part of its commitment to the medical imaging marketplace, Hitachi will continue to support sites that have purchased the SceptreP3, Schaffer said. The company did not disclose the size of this installed base.
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI
March 26th 2025In addition to a variety of tools to promote radiology workflow efficiencies, the integration of the Gravity AI tools into the PowerServer RIS platform may reduce time-consuming prior authorizations to minutes for completion.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.